-Search query
-Search result
Showing 1 - 50 of 74 items for (author: matsumoto & s)
EMDB-33643:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M
EMDB-33644:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M
PDB-7y6l:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M
PDB-7y6n:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M
EMDB-33065:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
Method: single particle / : Kamada K, Shirouzu M
EMDB-33066:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
Method: single particle / : Kamada K, Shirouzu M
EMDB-33067:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
Method: single particle / : Kamada K, Shirouzu M
EMDB-33068:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
Method: single particle / : Kamada K, Shirouzu M
PDB-7x93:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
Method: single particle / : Kamada K, Shirouzu M
PDB-7x94:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
Method: single particle / : Kamada K, Shirouzu M
PDB-7x95:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
Method: single particle / : Kamada K, Shirouzu M
PDB-7x96:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
Method: single particle / : Kamada K, Shirouzu M
EMDB-33059:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
EMDB-33060:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
EMDB-33061:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
EMDB-33062:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
EMDB-33063:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
EMDB-33064:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8w:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8y:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8z:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
PDB-7x90:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
PDB-7x91:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
PDB-7x92:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
EMDB-30915:
Apo spike protein of SARS-CoV2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30916:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody 8D2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30917:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-1
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30918:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30919:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-3
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30920:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-4
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30921:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (2940)-1
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30922:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (2940)-2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
PDB-7dzw:
Apo spike protein from SARS-CoV2
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
PDB-7dzx:
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
PDB-7dzy:
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
EMDB-21958:
The negative stain EM structure of the human DNA LigI-PCNA-DNA complex
Method: single particle / : Sverzhinsky A, Pascal JM
EMDB-22591:
Structure of Secretory IgM Core
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
PDB-7k0c:
Structure of Secretory IgM Core
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
EMDB-30233:
Cryo-EM structure of the human pathogen Mycoplasma pneumoniae P1
Method: single particle / : Kawamoto A, Kenri T
PDB-7bwm:
Cryo-EM structure of the human pathogen Mycoplasma pneumoniae P1
Method: single particle / : Kawamoto A, Kenri T, Namba K, Miyata M
EMDB-10406:
OCT4-SOX2-bound nucleosome - SHL-6
Method: single particle / : Michael AK, Kempf G, Cavadini S, Bunker RD, Thoma NH
EMDB-10408:
Nucleosome with OCT4-SOX2 motif at SHL-6
Method: single particle / : Michael AK, Kempf G
EMDB-10864:
OCT4-SOX2-bound nucleosome - SHL+6
Method: single particle / : Michael AK, Kempf G, Cavadini S, Bunker RD, Thoma NH
PDB-6t90:
OCT4-SOX2-bound nucleosome - SHL-6
Method: single particle / : Michael AK, Kempf G, Cavadini S, Bunker RD, Thoma NH
PDB-6t93:
Nucleosome with OCT4-SOX2 motif at SHL-6
Method: single particle / : Michael AK, Kempf G, Cavadini S, Bunker RD, Thoma NH
PDB-6yov:
OCT4-SOX2-bound nucleosome - SHL+6
Method: single particle / : Michael AK, Kempf G, Cavadini S, Bunker RD, Thoma NH
EMDB-20749:
Structure of dimeric sIgA complex
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
EMDB-20750:
Structure of tetrameric sIgA complex (Class 1)
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
EMDB-20751:
Structure of tetrameric sIgA complex (Class 2)
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
EMDB-20752:
Structure of pentameric sIgA complex
Method: single particle / : Kumar N, Arthur CP, Ciferri C, Matsumoto ML
Pages: